These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


348 related items for PubMed ID: 7937769

  • 1. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
    Song CZ, Loewenstein PM, Green M.
    Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9357-61. PubMed ID: 7937769
    [Abstract] [Full Text] [Related]

  • 2. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Tiley LS, Madore SJ, Malim MH, Cullen BR.
    Genes Dev; 1992 Nov 27; 6(11):2077-87. PubMed ID: 1427073
    [Abstract] [Full Text] [Related]

  • 3. Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.
    Carruth LM, Hardwick JM, Morse BA, Clements JE.
    J Virol; 1994 Oct 27; 68(10):6137-46. PubMed ID: 8083955
    [Abstract] [Full Text] [Related]

  • 4. A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA.
    Hart CE, Saltrelli MJ, Galphin JC, Schochetman G.
    J Virol; 1995 Oct 27; 69(10):6593-9. PubMed ID: 7666565
    [Abstract] [Full Text] [Related]

  • 5. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J, Frankel AD.
    Proc Natl Acad Sci U S A; 1993 Feb 15; 90(4):1571-5. PubMed ID: 8434019
    [Abstract] [Full Text] [Related]

  • 6. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.
    Luo Y, Madore SJ, Parslow TG, Cullen BR, Peterlin BM.
    J Virol; 1993 Sep 15; 67(9):5617-22. PubMed ID: 8350414
    [Abstract] [Full Text] [Related]

  • 7. Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain.
    Yu L, Zhang Z, Loewenstein PM, Desai K, Tang Q, Mao D, Symington JS, Green M.
    J Virol; 1995 May 15; 69(5):3007-16. PubMed ID: 7707527
    [Abstract] [Full Text] [Related]

  • 8. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C, Goldstrohm AC, Peng J, Price DH, Garcia-Blanco MA.
    Virology; 2000 Sep 01; 274(2):356-66. PubMed ID: 10964778
    [Abstract] [Full Text] [Related]

  • 9. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.
    Laspia MF, Rice AP, Mathews MB.
    Genes Dev; 1990 Dec 01; 4(12B):2397-408. PubMed ID: 2149119
    [Abstract] [Full Text] [Related]

  • 10. Functional interaction between the HIV transactivator Tat and the transcriptional coactivator PC4 in T cells.
    Holloway AF, Occhiodoro F, Mittler G, Meisterernst M, Shannon MF.
    J Biol Chem; 2000 Jul 14; 275(28):21668-77. PubMed ID: 10887206
    [Abstract] [Full Text] [Related]

  • 11. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L, Garcia J, Wu F, Modesti N, Nelson J, Gaynor R.
    Proc Natl Acad Sci U S A; 1990 Jul 14; 87(13):5079-83. PubMed ID: 2195547
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps.
    Jeang KT, Berkhout B.
    J Biol Chem; 1992 Sep 05; 267(25):17891-9. PubMed ID: 1517225
    [Abstract] [Full Text] [Related]

  • 13. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II.
    Okamoto H, Sheline CT, Corden JL, Jones KA, Peterlin BM.
    Proc Natl Acad Sci U S A; 1996 Oct 15; 93(21):11575-9. PubMed ID: 8876177
    [Abstract] [Full Text] [Related]

  • 14. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes.
    Ohana B, Moore PA, Ruben SM, Southgate CD, Green MR, Rosen CA.
    Proc Natl Acad Sci U S A; 1993 Jan 01; 90(1):138-42. PubMed ID: 8419915
    [Abstract] [Full Text] [Related]

  • 15. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J, Subramanian T, Chinnadurai G.
    Proc Natl Acad Sci U S A; 1991 Oct 01; 88(19):8510-4. PubMed ID: 1924310
    [Abstract] [Full Text] [Related]

  • 16. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
    Chowdhury M, Taylor JP, Chang CF, Rappaport J, Khalili K.
    J Virol; 1992 Dec 01; 66(12):7355-61. PubMed ID: 1331525
    [Abstract] [Full Text] [Related]

  • 17. The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.
    Delling U, Roy S, Sumner-Smith M, Barnett R, Reid L, Rosen CA, Sonenberg N.
    Proc Natl Acad Sci U S A; 1991 Jul 15; 88(14):6234-8. PubMed ID: 2068104
    [Abstract] [Full Text] [Related]

  • 18. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.
    Kato H, Sumimoto H, Pognonec P, Chen CH, Rosen CA, Roeder RG.
    Genes Dev; 1992 Apr 15; 6(4):655-66. PubMed ID: 1559613
    [Abstract] [Full Text] [Related]

  • 19. Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR.
    Luo Y, Peterlin BM.
    J Virol; 1993 Jun 15; 67(6):3441-5. PubMed ID: 8497060
    [Abstract] [Full Text] [Related]

  • 20. A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription.
    Xiao H, Tao Y, Greenblatt J, Roeder RG.
    Proc Natl Acad Sci U S A; 1998 Mar 03; 95(5):2146-51. PubMed ID: 9482853
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.